Moreover, our previous study in human samples (1) suggest a broad range of plasma ACE2 levels existing within the general population, since ACE2 expression and shedding can be altered in many common conditions such as hypertension, heart disease, diabetes or obesity, among many others. This evidence concerns the gene ACE2 and obesity due to melanocortin 4 receptor deficiency.